Cargando…
A novel defined TLR3 agonist as an effective vaccine adjuvant
Synthetic double-stranded RNA analogs recognized by Toll-like receptor 3 (TLR3) are an attractive adjuvant candidate for vaccines, especially against intracellular pathogens or tumors, because of their ability to enhance T cell and antibody responses. Although poly(I:C) is a representative dsRNA wit...
Autores principales: | Ko, Kwang Hyun, Cha, Seung Bin, Lee, Seung-Hwan, Bae, Hyun Shik, Ham, Chul Soo, Lee, Min-Gyu, Kim, Dong-Ho, Han, Seung Hyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902914/ https://www.ncbi.nlm.nih.gov/pubmed/36761735 http://dx.doi.org/10.3389/fimmu.2023.1075291 |
Ejemplares similares
-
Molecular Signatures of a TLR4 Agonist-Adjuvanted HIV-1 Vaccine Candidate in Humans
por: Anderson, Jenna, et al.
Publicado: (2018) -
Alum Adjuvant and Built-in TLR7 Agonist Synergistically Enhance Anti-MUC1 Immune Responses for Cancer Vaccine
por: Zhou, Shi-Hao, et al.
Publicado: (2022) -
Targeted Knockout of MDA5 and TLR3 in the DF-1 Chicken Fibroblast Cell Line Impairs Innate Immune Response Against RNA Ligands
por: Lee, Su Bin, et al.
Publicado: (2020) -
Bacterial Lipoproteins Induce BAFF Production via TLR2/MyD88/JNK Signaling Pathways in Dendritic Cells
por: Im, Jintaek, et al.
Publicado: (2020) -
RIG-I and TLR-7/8 agonists as combination adjuvant shapes unique antibody and cellular vaccine responses to seasonal influenza vaccine
por: Jangra, Sonia, et al.
Publicado: (2022)